4.1 Article

Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Don't forget eclampsia in the efforts to reduce maternal morbidity and mortality

Wanda K. Nicholson et al.

Summary: Hypertensive disorders are a major cause of maternal morbidity and mortality worldwide. Partnership between healthcare professionals and policy makers, along with increased resources, training, and postpartum care, is essential to reduce the risks associated with these conditions. Culturally appropriate education and sustained efforts can help prevent eclampsia and its complications.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)

Review Multidisciplinary Sciences

Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis

Rachel Van Doorn et al.

Summary: The study found that a dose of 150 mg aspirin significantly reduced the risk of preterm preeclampsia, while other doses did not show significant reductions. All doses of aspirin showed a maximum 30% reduction in the risk of all gestational age preeclampsia.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy

Xiaojuan Han et al.

Summary: This study demonstrated that Quercetin inhibits NLRP3 inflammasome activation in microglia by promoting mitophagy, thus preventing neuronal injury and providing a potential novel therapeutic strategy for neuroinflammation-related diseases.

REDOX BIOLOGY (2021)

Article Obstetrics & Gynecology

Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia

Oliver Graupner et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)

Article Medicine, Research & Experimental

The bioflavonoid quercetin improves pathophysiology in a rat model of preeclampsia

Qinghua Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Correction Urology & Nephrology

Pre-eclampsia: pathogenesis, novel diagnostics and therapies (vol 15, pg 275, 2019)

Elizabeth A. Phipps et al.

NATURE REVIEWS NEPHROLOGY (2019)

Article Medicine, Research & Experimental

Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME

Shuangyan Yang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Obstetrics & Gynecology

Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia

Kate Navaratnam et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)

Review Biochemistry & Molecular Biology

Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery

Nicholas Ekow Thomford et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Food Science & Technology

Antioxidant and anti-inflammatory activities of quercetin and its derivatives

Marija Lesjak et al.

JOURNAL OF FUNCTIONAL FOODS (2018)

Article Obstetrics & Gynecology

Exploring the role of mitochondrial dysfunction in the pathophysiology of pre-eclampsia

Rachel D. Williamson et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)

Review Peripheral Vascular Disease

Pathophysiology and Current Clinical Management of Preeclampsia

Lorena M. Amaral et al.

CURRENT HYPERTENSION REPORTS (2017)

Review Immunology

Molecular mechanisms regulating NLRP3 inflammasome activation

Eun-Kyeong Jo et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2016)

Review Nutrition & Dietetics

Quercetin, Inflammation and Immunity

Yao Li et al.

NUTRIENTS (2016)

Review Biochemistry & Molecular Biology

Vasodilator Compounds Derived from Plants and Their Mechanisms of Action

Francisco J. Luna-Vazquez et al.

MOLECULES (2013)

Article Oncology

Comparison of developmental toxicology of aspirin,(acetylsalicylic acid) in rats using selected dosing paradigms

U Gupta et al.

BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2003)